🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Treatment for sublesional bone loss (osteoporosis) in persons with chronic,...
Status
Active Not Recruiting
Location
Kessler Institute for Rehabilitation
Start Date
2021-03-01
Trial ID
NCT04232657
Treatments Being Tested
To determine the effect of denosumab treatment compared with placebo over 1...
Status
Completed
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT00043186
Treatments Being Tested
This study will compare the effectiveness of denosumab treatment every 6 mo...
Status
Completed
Location
Research Site
Start Date
2012-11-07
Trial ID
NCT01732770
Treatments Being Tested
This randomized controlled trial aims to assess whether treatment with deno...
Status
Completed
Location
Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine
Start Date
2024-03-01
Trial ID
NCT06300229
Treatments Being Tested
Through the method of a clinical randomized controlled trial, patients meet...
Status
Unknown
Location
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Start Date
2024-02-01
Trial ID
NCT06154707
Treatments Being Tested
Evaluation of bone mineral density and function at 1 year after screw inter...
Status
Withdrawn
Location
ShenzhenPH
Start Date
2021-09-14
Trial ID
NCT05065164
Treatments Being Tested
This is a randomized, 2-arm phase II, placebo-controlled, multi-center stud...
Status
Completed
Location
IIIrd Medical Department, Private Medical University Hospital Salzburg
Start Date
2019-09-30
Trial ID
NCT03792763
Treatments Being Tested
Studies objectives: To evaluate the safety, tolerability and efficacy of A...
Status
Withdrawn
Location
Soroka Medical Center
Start Date
2022-06
Trial ID
NCT02864784
Treatments Being Tested
This study evaluates single dose of Denosumab in decreasing systemic and pe...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10-01
Trial ID
NCT05559268
Treatments Being Tested